CD8+ T cells are the main component of the anti-tumor immune response, eliminating target cells through exocytosis of effector cytokines such as granzyme B (Gzmb), interferon (IFN)-γ and TNF-α 32. This evidence concerns the gene CD8A and neoplasm.